Published in J Contemp Brachytherapy on August 30, 2017
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys (2006) 11.17
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol (2015) 3.18
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol (2015) 3.03
Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. Eur Urol (2014) 2.47
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet (2017) 2.33
10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys (2001) 2.30
Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol (2007) 2.26
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy (2012) 2.03
Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology (2002) 2.01
Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting. Eur Urol (2014) 1.65
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol (2010) 1.61
What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.55
Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy. BJU Int (2015) 1.49
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy. J Nucl Med (2015) 1.44
Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer (1992) 1.34
Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. Eur Urol (2016) 1.27
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. J Nucl Med (2015) 1.21
Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int (2014) 1.18
Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. Radiology (2001) 1.10
Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer. BJU Int (2012) 1.05
Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer. Int J Radiat Oncol Biol Phys (2008) 1.01
Role of MRI in follow-up after focal therapy for prostate carcinoma. AJR Am J Roentgenol (2010) 1.01
Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy. J Urol (2012) 1.01
Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys (2012) 1.00
Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. Med Phys (2012) 0.96
Can we deliver randomized trials of focal therapy in prostate cancer? Nat Rev Clin Oncol (2014) 0.94
Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life. Radiother Oncol (2014) 0.93
Functional MRI for radiotherapy dose painting. Magn Reson Imaging (2012) 0.92
MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Radiology (2014) 0.91
Prostate multimodality image registration based on B-splines and quadrature local energy. Int J Comput Assist Radiol Surg (2011) 0.89
Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. Biomed Res Int (2014) 0.89
Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project. World J Urol (2015) 0.88
Assessment of i-125 prostate implants by tumor bioeffect. Int J Radiat Oncol Biol Phys (2004) 0.87
Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. Int J Radiat Oncol Biol Phys (2011) 0.85
Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment. Brachytherapy (2013) 0.84
Dosimetry Modeling for Focal Low-Dose-Rate Prostate Brachytherapy. Int J Radiat Oncol Biol Phys (2015) 0.83
Biomechanical modeling constrained surface-based image registration for prostate MR guided TRUS biopsy. Med Phys (2015) 0.82
Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility study. Brachytherapy (2013) 0.82
Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature. J Contemp Brachytherapy (2016) 0.82
Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints. Radiother Oncol (2015) 0.82
Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother Oncol (2014) 0.81
Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy? Clin Oncol (R Coll Radiol) (2013) 0.81
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial. Radiother Oncol (2016) 0.81
Dosimetry modeling for focal high-dose-rate prostate brachytherapy. Brachytherapy (2014) 0.81
High dose rate brachytherapy boost for prostate cancer: a systematic review. Cancer Treat Rev (2013) 0.81
The use of probability maps to deal with the uncertainties in prostate cancer delineation. Radiother Oncol (2010) 0.80
Rectal dose constraints for salvage iodine-125 prostate brachytherapy. Brachytherapy (2015) 0.79
Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer. J Contemp Brachytherapy (2016) 0.79
Comparison of focal boost high dose rate prostate brachytherapy optimisation methods. Radiother Oncol (2015) 0.79
Advances in the treatment of prostate cancer with radiotherapy. Crit Rev Oncol Hematol (2015) 0.79
Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy. Brachytherapy (2010) 0.79
Focal brachytherapy for selected low-risk prostate cancers: a pilot study. Brachytherapy (2013) 0.79
Comparison of (68)Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology. Theranostics (2017) 0.78
Focal therapy for localised prostate cancer: are we asking the correct research questions? BJU Int (2012) 0.78
Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer. Acta Oncol (2015) 0.78
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. Eur Urol (2016) 0.77
Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers. World J Urol (2015) 0.77
Point: the relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: is there an elephant in the room? Brachytherapy (2010) 0.77
Development of a registration framework to validate MRI with histology for prostate focal therapy. Med Phys (2015) 0.77
Options for Salvage of Radiation Failures for Prostate Cancer. Semin Radiat Oncol (2016) 0.76
Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning. Brachytherapy (2013) 0.76
An automated optimization tool for high-dose-rate (HDR) prostate brachytherapy with divergent needle pattern. Phys Med Biol (2015) 0.76
Quantitative Imaging in Radiation Oncology: An Emerging Science and Clinical Service. Semin Radiat Oncol (2015) 0.76
Predicting prostate tumour location from multiparametric MRI using Gaussian kernel support vector machines: a preliminary study. Australas Phys Eng Sci Med (2017) 0.76
Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer. J Contemp Brachytherapy (2017) 0.76
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome. Radiother Oncol (2010) 0.76
Optimal source distribution for focal boosts using high dose rate (HDR) brachytherapy alone in prostate cancer. Radiother Oncol (2014) 0.76
Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning. Semin Radiat Oncol (2016) 0.75
A radiobiology-based inverse treatment planning method for optimisation of permanent l-125 prostate implants in focal brachytherapy. Phys Med Biol (2015) 0.75
Focal low-dose rate brachytherapy for the treatment of prostate cancer. Cancer Manag Res (2013) 0.75
Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion. Prostate Cancer (2016) 0.75
2D Ultrasound and 3D MR Image Registration of the Prostate for Brachytherapy Surgical Navigation. Medicine (Baltimore) (2015) 0.75